Vimta Labs Ltd.

VIMTALABS

Market Cap
₹932 Cr.
P/E
22.50

Vimta Labs Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Forensics
Other Income
Other Income is not affecting ratios of the company
Pledge
Promoters have not pledged a significant portion of their holding
Revenue Recognition
Company is converting accounting profit to cash
Depreciation Effect
Depreciation accounting is not leading to increase in profits
Capex vs ROCE
ROCE of the company has increased over the last three years
Contingent Liabilities
Company does not have significant contingent liabilities
Retail Holding
Retail has been buying the stock which is usually a sign of exuberance
Share price
Share price has increased over last 10 years due to earnings
ROE
Net Profit Margin is responsible for ROE increase over last 10 years
Working Capital
Working Capital of the company seems to be under control
Debt
Company should not have issues servicing its debt
Current vs Historic Valuation
Company is trading at a premium to 3yr historic valuations
Promoter Holding
Promoter has not sold any shares in the last 90 days
ROE
Latest
17.1%
3yr Average
15.26%
5yr Average
12.9%
Net Profit Margin
Latest
15.14%
3yr Average
13.38%
5yr Average
11.17%
ROCE
Latest
22.49%
3yr Average
19.73%
5yr Average
17.21%
Debt to Equity
Latest
0.05
3yr Average
0.1
5yr Average
0.13
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • Management Compensation as a % of Sales (%)
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Vimta Labs Ltd.
    View the discussion on ValuePickr
    Vimta Labs Ltd – Bet on the emerging theme of Contract Research & Testing Outsourcing - SOC Invest
    Diagnostics
    How The Diagnostics Industry Works - PPFAS
    Diagnostic Industry - P2P Analysis - SOIC
    Impact on compeitition like TATA1MG on Diagnostics Sector - Aditya Khemka(Incred) - Bloomberg Quint
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Phama Industry - Terminologies and Value Chain - Alpha Invesco
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    timeline
    Sign Up for Free